419 related articles for article (PubMed ID: 1850473)
1. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
Yue TL; Stadel JM; Sarau HM; Friedman E; Gu JL; Powers DA; Gleason MM; Feuerstein G; Wang HY
Mol Pharmacol; 1992 Feb; 41(2):281-9. PubMed ID: 1311408
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor induced calcium mobilization and phosphoinositide metabolism in cultured bovine cerebral microvascular endothelial cells.
Lin AY; Rui YC
Biochim Biophys Acta; 1994 Nov; 1224(2):323-8. PubMed ID: 7981248
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture.
Barzaghi G; Sarau HM; Mong S
J Pharmacol Exp Ther; 1989 Feb; 248(2):559-66. PubMed ID: 2537401
[TBL] [Abstract][Full Text] [Related]
5. Characterization of platelet-activating factor-induced elevation of cytosolic free-calcium level in neurohybrid NCB-20 cells.
Yue TL; Gleason MM; Hallenbeck J; Feuerstein G
Neuroscience; 1991; 41(1):177-85. PubMed ID: 2057061
[TBL] [Abstract][Full Text] [Related]
6. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
Chen J; Giri SN
J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor (PAF) induces a contraction of isolated smooth muscle cells from guinea pig ileum: intracellular pathway involved.
Jeanneton O; Delvaux M; Botella A; Frexinos J; Bueno L
J Pharmacol Exp Ther; 1993 Oct; 267(1):31-7. PubMed ID: 8229757
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
10. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
Ukena D; Dent G; Chanez P; Barnes PJ; Sybrecht GW
Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo.
Yue TL; Rabinovici R; Farhat M; Feuerstein G
J Lipid Mediat; 1991; 3(1):13-26. PubMed ID: 1768837
[TBL] [Abstract][Full Text] [Related]
12. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
Saeed SA; Rasheed H
Acta Pharmacol Sin; 2003 Jan; 24(1):31-6. PubMed ID: 12511226
[TBL] [Abstract][Full Text] [Related]
13. Mechanism and regulation of neutrophil priming by platelet-activating factor.
Gay JC
J Cell Physiol; 1993 Jul; 156(1):189-97. PubMed ID: 8391006
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
Morrison WJ; Shukla SD
J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
[TBL] [Abstract][Full Text] [Related]
16. Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation.
James-Kracke MR; Sexe RB; Shukla SD
J Pharmacol Exp Ther; 1994 Nov; 271(2):824-31. PubMed ID: 7965802
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
[TBL] [Abstract][Full Text] [Related]
19. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
Floch A; Tahraoui L; Sedivy P; Cavero I
J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of platelet-activating factor receptors in lung and alveolar macrophages in the bleomycin-hamster model of pulmonary fibrosis.
Chen J; Ziboh V; Giri SN
J Pharmacol Exp Ther; 1997 Mar; 280(3):1219-27. PubMed ID: 9067307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
